Cover Image

Xanthonychia Due to Staining From Carbidopa-Levodopa

Saved in:

Bibliographic Details
Main Authors:	Jonathan Kyle Hwang (Author), Shari Lipner (Author)
Format:	Book
Published:	Mattioli1885, 2023-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmaceutical and pharmacokinetic evaluation of a newly formulated multiparticulate matrix of levodopa and carbidopa
by: Emelia Priscilla Imbeah, et al.
Published: (2022)

A case of carbidopa/levodopa associated colitis mimicking inflammatory bowel disease
by: Michael J. Steel, et al.
Published: (2022)

Chitosan-Coated Hydroxypropylmethyl Cellulose Microparticles of Levodopa (and Carbidopa): In Vitro and Rat Model Kinetic Characteristics
by: Benedicta Obenewaa Dankyi, MPhil, et al.
Published: (2020)

Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson's disease: systematic review, meta-analysis, and economic evaluation
by: Yi ZM, et al.
Published: (2018)

The Advantages of Levodopa-Carbidopa Intestinal Gel for Patients with Advanced Parkinson’s Disease: A Systematic Review
by: Zhang XR, et al.
Published: (2020)

Istradefylline: A novel agent in the treatment of "off" episodes associated with levodopa/carbidopa use in Parkinson disease
by: Lauren Cummins, et al.
Published: (2022)

Large left posterior fossa meningioma presenting with quadriplegia in a woman with history of carbidopa-levodopa resistant parkinsonism
by: Antonio Jose Reyes, et al.
Published: (2019)

Levodopa-Entacapone-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson's Disease: A Single Center Real-World Experience
by: Szabolcs Szatmári, et al.
Published: (2024)

Development and Validation of a Robust and Efficient HPLC Method for the Simultaneous Quantification of Levodopa, Carbidopa, Benserazide and Entacapone in Complex Matrices
by: Erik Wollmer, et al.
Published: (2017)

Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease: Observations and Dilemmas after 10 Years of Real-Life Experience
by: József Attila Szász, et al.
Published: (2022)

Poly(acrylic acid)/Poly(vinyl alcohol) Microarray Patches for Continuous Transdermal Delivery of Levodopa and Carbidopa: In Vitro and In Vivo Studies
by: Yaocun Li, et al.
Published: (2024)

Metabolite profiling of foslevodopa/foscarbidopa in plasma of healthy human participants by LC‐HRMS indicates no major differences compared to administration of levodopa/carbidopa intestinal gel
by: John P. Savaryn, et al.
Published: (2024)

Parkinson's disease: carbidopa, nausea, and dyskinesia
by: Hinz M, et al.
Published: (2014)

Assessing the Neurotoxicity of a Sub-Optimal Dose of Rotenone in Zebrafish (<i>Danio rerio</i>) and the Possible Neuroactive Potential of Valproic Acid, Combination of Levodopa and Carbidopa, and Lactic Acid Bacteria Strains
by: Ovidiu-Dumitru Ilie, et al.
Published: (2022)

Carbidopa Capsules for Insulinoma Diagnostic: Compounding and Stability Study
by: Curti Christophe, et al.
Published: (2020)

Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Retraction]
by: Hinz M, et al.
Published: (2021)

Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Expression of Concern]
by: Hinz M, et al.
Published: (2020)

Levodopa versus levodopa sparing in early parkinson's disease: can we meet halfway?
by: Mayela Rodríguez-Violante, et al.
Published: (2024)

The human experience with intravenous levodopa
by: Shan H Siddiqi, et al.
Published: (2016)

The Parkinson's disease death rate: carbidopa and vitamin B6
by: Hinz M, et al.
Published: (2014)

Pharmacokinetics of Levodopa and 3-O-Methyldopa in Parkinsonian Patients Treated with Levodopa and Ropinirole and in Patients with Motor Complications
by: Urszula Adamiak-Giera, et al.
Published: (2021)

The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Retraction]
by: Hinz M, et al.
Published: (2021)

Benign Hereditary Chorea: Response to Levodopa
by: J Gordon Millichap
Published: (2012)

The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Expression of Concern]
by: Hinz M, et al.
Published: (2020)

Bullous Lichen Planus of the Nails: A Case Report and Review of the Literature
by: Jonathan K. Hwang, et al.
Published: (2023)

Levodopa/benserazide microspheres reduced levodopa-induced dyskinesia by downregulating phosphorylated GluR1 expression in 6-OHDA-lesioned rats
by: Song L,Yuan W, et al.
Published: (2012)

Levodopa Dose-Limiting Dyskinesias in Treatment of Segawa Disease
by: J Gordon Millichap
Published: (2012)

Basal ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia
by: Pedro eBarroso Chinea, et al.
Published: (2010)

Levodopa-benserazide Interaction with Enteral Nutrition: A Case Report
by: Foroud Shahbazi, et al.
Published: (2018)

Spray Dried Levodopa-Doped Powder Potentially for Intranasal Delivery
by: Xuan Liu, et al.
Published: (2022)

Design and Development of Levodopa Loaded Polymeric Nanoparticles for Intranasal Delivery
by: Mohd Zulhelmy Ahmad, et al.
Published: (2022)

Levodopa-induced Dyskinesias in Parkinson's Disease: Current Knowledge and Future Scenarios
by: Francesca Morgante
Published: (2015)

Parkinson's disease: general features, effects of levodopa treatment and future directions
by: Marco Aurelio M Freire, et al.
Published: (2010)

Levodopa in Parkinson's Disease: A Review of Population Pharmacokinetics/Pharmacodynamics Analysis
by: Amélie Marsot, et al.
Published: (2017)

Low utilization of confirmatory testing for tinea capitis by pediatricians at an academic center in New York, United States, 2005-2021
by: Jonathan K. Hwang, et al.
Published: (2023)

Pharmacokinetics and tolerability of inhaled levodopa from a new dry-powder inhaler in patients with Parkinson's disease
by: Marianne Luinstra, et al.
Published: (2019)

Importance of Board-Certified Dermatologist Online Reviews: Small Steps to Improve Patient Experiences and Perspectives
by: Julianne Falotico, et al.
Published: (2023)

Analysis of Genetic and Non-genetic Predictors of Levodopa Induced Dyskinesia in Parkinson's Disease
by: Alfonsina Tirozzi, et al.
Published: (2021)

Proteomics Reveal the Inhibitory Mechanism of Levodopa Against Esophageal Squamous Cell Carcinoma
by: Zhenzhen Li, et al.
Published: (2020)

Potential efficacy of nanocurcumin on levodopa-induced dyskinesia in a rat parkinsonian model
by: Pegah Ashrafi, et al.
Published: (2022)